MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ofid/ofag511

Медицинская библиотека · Open forum infectious diseases · 2026

Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo).

Avenoso Daniele, Farina Mirko, Ferri Simone, Masina Lorenzo, Signorini Liana, Lorenzotti Silvia, Van Hauwermeiren Evelyn, Canino Biagio Francesco, Corbellini Silvia, Caccuri Francesca, Magliano Gabriele, Morello Enrico, Radici Vera, Bernardi Simona, Re Federica, Leoni Alessandro, Caruso Arnaldo, Russo Domenico, Malagola Michele

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Infectious complications and antimicrobial resistance (AMR) are leading causes of morbidity and non-relapse mortality (NRM) in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). The BATMO protocol, implemented in 2019, removed fluoroquinolone prophylaxis and introduced a personalized, stewardship-based antimicrobial approach.

METHODS

We retrospectively analyzed 323 allo-HSCT recipients transplanted between 2016 and 2023 at a single center, comparing outcomes in patients before (n = 115) and after (n = 208) BATMO implementation. Primary endpoints included overall survival (OS), NRM, incidence and microbiology of bloodstream infections (BSIs), antimicrobial resistance trends, and carbapenem use. Kaplan-Meier and cumulative incidence methods were employed.

RESULTS

Despite a significant increase in 30-day Gram-negative BSI incidence post-BATMO (24% vs 15%, P = .03), OS and NRM were similar between the two cohorts. Notably, the post-BATMO cohort included a substantially higher proportion of high-risk transplants, with a marked increase in haploidentical procedures and broader use of post-transplant cyclophosphamide. Interestingly, fluoroquinolone-resistant E. coli strains declined from 100% to 46% (P = .003), and overall Gram-negative resistance dropped from 75% to 36% (P = .006). Use of carbapenems remained unchanged (43% vs 53%, P = .1).

CONCLUSIONS

The BATMO protocol demonstrates that withdrawal of fluoroquinolone prophylaxis and implementation of a targeted antimicrobial strategy can reduce resistance without compromising transplant outcomes. These findings support the long-term safety and efficacy of stewardship-based approaches in allo-HSCT.

Для цитирования: Avenoso Daniele, Farina Mirko, Ferri Simone, Masina Lorenzo, Signorini Liana, Lorenzotti Silvia, Van Hauwermeiren Evelyn, Canino Biagio Francesco, Corbellini Silvia, Caccuri Francesca, Magliano Gabriele, Morello Enrico, Radici Vera, Bernardi Simona, Re Federica, Leoni Alessandro, Caruso Arnaldo, Russo Domenico, Malagola Michele. Fluoroquinolone-Free Prophylaxis and Impact on Bacterial Infections, Resistance, and Survival in Allo-HSCT: 5-Year Follow-up of the BATMO Protocol (Best Anti-microbical Therapy Trapianto di Midollo Osseo).. Open forum infectious diseases. 2026. DOI: 10.1093/ofid/ofag511.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.